Alkem Laboratories Doubles Investment for Ujjain Greenfield Facility

Alkem Laboratories Limited has announced a significant upward revision in its investment plans for its upcoming manufacturing unit in Madhya Pradesh. In a regulatory filing dated April 2, 2026, the company informed the stock exchanges that its Board of Directors has approved nearly doubling the initial capital outlay for the project.

This follows an earlier announcement made on March 18, 2026, regarding the allotment of 30 acres of land at the Industrial Area DMIC Vikram Udyogpuri Limited, Phase-2, Ujjain. The facility is slated to be a greenfield formulations manufacturing plant.

Key Investment Details

The Board has approved an increase in the total investment from the previously sanctioned ₹533 crore to a new ceiling of ₹1,036 crore. This capital will be deployed in a phased manner to establish and scale the manufacturing operations in Ujjain.

The move signals Alkem's aggressive expansion strategy to bolster its production capacity for pharmaceutical formulations. By setting up a greenfield project (a facility built from the ground up on previously undeveloped land), the company aims to leverage modern infrastructure and technology to meet growing market demands.

Shares of Alkem Laboratories Limited was last trading in BSE at Rs. 5257.10 as compared to the previous close of Rs. 5240.45. The total number of shares traded during the day was 1336 in over 593 trades.

The stock hit an intraday high of Rs. 5271.35 and intraday low of 5085.00. The net turnover during the day was Rs. 6893313.00.

Source : Equity Bulls

Keywords

AlkemLaboratories INE540L01014 Pharmaceuticals Investment Ujjain GreenfieldFacility